What is the importance of the new ESH/ESC hypertension guideline?

Stroke, atrial fibrillation and NOACs

CV event prevention in type-2 diabetes

How to use the free UK Biobank for cardiac research?

Residual CV risk in post-MI patients

What’s new in the 2018 ESH/ESC Hypertension guideline?

How to prevent major cardiovascular complications in type-2 diabetes?

COMPASS trial update at ESC2018

MANAGE and RE-DUAL trial updates at ESC2018

New ESC/ESC hypertension guideline

How much did heart surgery develop in last years?

Coronary risk and risk stratification

How to reduce premature cardiovascular mortality in type-2 diabetes?

How to assess NOAC anticoagulant activity in emergency situations?

EHRA practical guide for treatment of atrial fibrillation patients

How can we translate the new GLP-1 outcome trials into clinical practice?